tiprankstipranks
Trending News
More News >
Kala Pharmaceuticals: Promising Clinical Developments and Financial Stability Support Buy Rating
PremiumRatingsKala Pharmaceuticals: Promising Clinical Developments and Financial Stability Support Buy Rating
2M ago
Kala Pharmaceuticals management to meet with Oppenheimer
Premium
The Fly
Kala Pharmaceuticals management to meet with Oppenheimer
2M ago
KALA BIO Advances Eye Disease Therapies with New Funding
Premium
Company Announcements
KALA BIO Advances Eye Disease Therapies with New Funding
2M ago
Kala Pharmaceuticals files to sell 1.67M shares of common stock for holders
PremiumThe FlyKala Pharmaceuticals files to sell 1.67M shares of common stock for holders
4M ago
Kala Bio to sell 1.34M shares at $6.44 in private placement
Premium
The Fly
Kala Bio to sell 1.34M shares at $6.44 in private placement
5M ago
Kala Bio Advances PCED Treatment Amid Financial Update
Premium
Company Announcements
Kala Bio Advances PCED Treatment Amid Financial Update
7M ago
Kala Pharmaceuticals reports Q2 EPS ($3.16) vs ($4.36) last year
PremiumThe FlyKala Pharmaceuticals reports Q2 EPS ($3.16) vs ($4.36) last year
10M ago
Kala Pharmaceuticals files to sell 3.52M shares of common stock for holders
Premium
The Fly
Kala Pharmaceuticals files to sell 3.52M shares of common stock for holders
11M ago
Kala Pharmaceuticals to sell 1.197M shares at $5.85 in private placement
Premium
The Fly
Kala Pharmaceuticals to sell 1.197M shares at $5.85 in private placement
12M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100